Abstract
The 11th biannual report of the Cochrane Haematological Malignancies Group highlights recently published randomized controlled trials in the field of hemato-oncology that were identified through the continuous systematic search of MEDLINE. For this electronic search, a broad search filter covering all topics in hemato-oncology was combined with a highly sensitive search filter for randomized studies. This report covers publications from February 1, 2009, through August 31, 2009 (including electronic publications). For this 7-month period, 6344 potentially interesting articles were screened to identify 121 controlled clinical trials (randomized controlled trials or quasi-randomized clinical trials) of therapeutic interventions in hematologic malignancies.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anemia / chemically induced
-
Anemia / prevention & control
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Azacitidine / administration & dosage
-
Bendamustine Hydrochloride
-
Bleomycin / administration & dosage
-
Chlorambucil / administration & dosage
-
Controlled Clinical Trials as Topic
-
Cyclophosphamide / administration & dosage
-
Dacarbazine / administration & dosage
-
Doxorubicin / administration & dosage
-
Etoposide / administration & dosage
-
Exercise
-
Hematinics / therapeutic use
-
Hodgkin Disease / drug therapy*
-
Humans
-
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
-
Multicenter Studies as Topic
-
Myelodysplastic Syndromes / drug therapy
-
Nitrogen Mustard Compounds / administration & dosage
-
Prednisone / administration & dosage
-
Procarbazine / administration & dosage
-
Quality of Life
-
Randomized Controlled Trials as Topic
-
Vinblastine / administration & dosage
-
Vincristine / administration & dosage
Substances
-
Hematinics
-
Nitrogen Mustard Compounds
-
Bleomycin
-
Chlorambucil
-
Procarbazine
-
Vincristine
-
Vinblastine
-
Etoposide
-
Dacarbazine
-
Doxorubicin
-
Cyclophosphamide
-
Bendamustine Hydrochloride
-
Azacitidine
-
Prednisone
Supplementary concepts
-
ABVD protocol
-
BEACOPP protocol